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Abstract
Purpose—The National Breast and Cervical Cancer Early Detection Program through each 
state's administration serves millions of low-income and uninsured women aged 40–64. Our 
purpose was to assess whether cases screened through Georgia's Breast and Cervical Cancer 
Program (BCCP) were diagnosed at an earlier stage of disease and whether those who used the 
state's program regularly continued to obtain age-appropriate screens as they aged out of BCCP 
into Medicare between 2000 and 2005.
Methods—We used BCCP screening data to identify women with more than one screen and an 
interval of 18 months or less between screens as “regular” users of BCCP. Using the linked BCCP 
and Medicare enrollment/claims data, we tested whether women with any BCCP use (n = 3,134) 
or “regular” users (n = 1,590) were more likely than women not using BCCP (n = 10,086) to 
exhibit regular screening under Medicare. We used linked BCCP and Georgia Cancer Registry 
data to examine breast cancer incidence and stage at diagnosis of BCCP women compared to the 
Georgia population.
Results—Under Medicare, almost 63 % of women with any BCCP use were re-screened versus 
51 % of non-BCCP users. The probability of being screened within 18 months of Medicare 
enrollment was 3.5 % points higher for any BCCP user and 17.7 points higher for “regular” BCCP 
users, compared to nonusers. Among Black non-Hispanics, the difference for any BCCP user was 
13.7 % points and for regular users, 22.4 % points. A larger percentage of BCCP users were 
diagnosed at in situ or localized disease stage than overall.
E. Kathleen Adams eadam01@emory.edu. 
Conflict of interest The authors declare that they have no conflict of interest.
HHS Public Access
Author manuscript
Cancer Causes Control. Author manuscript; available in PMC 2016 May 01.
Published in final edited form as:













Conclusions—The majority of women aging out of the GA BCCP 2000–2005 had used the 
program to obtain regular mammography. Regular users of GA BCCP continued to be screened 





The National Breast and Cervical Cancer Early Detection Program (NBCCEDP), established 
in 1990 and funded through the Centers for Disease Control and Prevention (CDC), provides 
important access to low-income women by providing free clinical breast examinations, 
mammograms, Pap tests, pelvic examinations, human papillomavirus (HPV) tests, 
diagnostic tests for abnormal results, and referrals to treatment [1]. NBCCEDP eligibility is 
generally extended to uninsured and underinsured women at or below 250 % of federal 
poverty level (FPL), but state income eligibility levels and other administrative details vary. 
While approximately 9–10 % of US women are eligible for NBCCEDP, it serves 8–12 % of 
these women due in part to limitations on funding [1].
Since 1995, Georgia has participated in the NBCCEDP with a program known as the 
“Breast and Cervical Cancer Program” or “BCCP.” Women can access BCCP services in all 
county public health clinics as well as in some private clinics that partner with the BCCP. 
The BCCP targets women aged 50–64 for breast cancer screening and those never/rarely 
screened. The BCCP considers a “rarely screened” woman as one who has not had a 
mammogram within the past 5 years. In addition to providing free clinical cancer screening 
services, the BCCP uses client navigators to offer support to BCCP case manager nurses and 
to conduct population-based education regarding breast, cervical, and colorectal cancers; a 
key goal is to encourage age-appropriate screening patterns. The BCCP began using client 
navigators in 2001, and their state partnership with the American Cancer Society (ACS) to 
operate this aspect of the program was established in 2011. Between 2008 and 2012, the 
BCCP served 40,071 women and provided 39,048 breast cancer screenings.
The NBCCEDP has been shown to be important for screening of low-income, uninsured 
women. As the NBCCEDP state programs matured in the latter 1990s, the percentage of all 
non-elderly women receiving Pap test, clinical breast examination (CBE), and 
mammography increased [2, 3]. Studies also indicate improvement over time within the 
NBCCEDP in reducing time to diagnosis [4, 5] and treatment [4] among NBCCEDP users 
with abnormal CBE or mammogram results. Newer studies indicate an association with 
reduced breast cancer mortality rate [6, 7]. Additionally, adding case management as a 
formal component in 2000 was perceived by state program managers to decrease the delay 
in follow-up and diagnostic services for women screened through the NBCCEDP [4, 8]. 
This result supports other studies that suggest the NBCCEDP case managers and other 
patient navigator programs can improve patients' timeliness to diagnosis, decrease patients' 
anxiety, and increase overall care satisfaction [5, 9]. The BCCP uses educational materials 
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and consistent follow-up to encourage women to repeat screening at an interval of <18 or 24 
months.
Repeat breast cancer screening is lowest among those with less than a college education, low 
income, and lack of insurance [10]. While older women (50+) are more likely than younger 
women to report screening within the past 2 years, a quarter of older women do not receive 
appropriate and timely mammography [11].
In this study, we examined the breast cancer screening patterns among women using the 
BCCP in GA and reaching Medicare age (65) between 2000 and 2005. Our goals were to 
assess whether, as they aged into Medicare coverage, their use of the BCCP influenced their 
screening behaviors compared to non-BCCP users of similar age, race/ethnicity, and similar 
geographic areas and in turn, whether it was associated with an earlier stage among those 
who did experience a breast cancer diagnosis.
Materials and methods
After obtaining institutional review board approval, we conducted a retrospective study 
focused on breast cancer screening and the incidence of breast cancer cases in Georgia for 
BCCP and non-BCCP women using several sources of data.
Data and linkage
We used data from: (1) BCCP enrollment and visit records; (2) Medicare Beneficiary 
Summary files (MBSF, BASF) and carrier claims files from the Centers for Medicare and 
Medicaid Services (CMS); and (3) Georgia Cancer Registry (GCR) in our analysis. We used 
the BCCP data to identify women who received at least one breast cancer screening or 
diagnostic procedure paid by the BCCP in Georgia and who turned 65 years of age between 
2000 and 2007 and hence aged into Medicare in this period (n = 9,587); see Table 1 for a 
flowchart of full sample derivation.
A roster of IDs (Social Security Number (SSN), date of birth (DOB), and zip code) for these 
9, 587 women was sent to CMS for linkage 2000–2007; CMS matched only on SSN and 
DOB so we would have data on women in the Medicare files 2000–2007 who had used the 
BCCP but may now reside elsewhere. We restricted our analytic sample to those aging out 
of the GA BCCP from 2000 to 2005 (n = 4,796) to observe their Medicare claims for at least 
24 months. Of these women, we kept only those with: (1) SSN and exact DOB matching or 
(2) SSN and BCCP and Medicare DOB <1 week apart or same day/month but different 
years (n = 3,666). From this group, as well as the matched comparison group (discussed 
below), we excluded those with evidence of HMO enrollment in the first 24 months of 
Medicare enrollment since we only observe full claims experience for women in the 
Medicare fee-for-service sector; this sample included 3,134 BCCP women.
Since women can qualify for Medicare coverage before age 65 due to disability, we 
identified this group (9.7 % of BCCP women) and used the woman's actual Medicare start 
date if it occurred between 2000 and 2005. If the start date was before 2000 (2.7 % of BCCP 
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women), we used the date they turned 65 as their Medicare start date for the purpose of this 
analysis. We control for disability status in our analysis.
Comparison group
CMS also provided data on non-BCCP women who aged into Medicare during 2000–2007 
at the same time as BCCP women from similar GA zip codes; a comparison sample was 
drawn from these data. From the full CMS sample, we derived a random control sample of 
three Medicare enrolled women for each BCCP woman. We matched first based on race, 
year aging out, and zip code. While 85 % matched using these criteria, we subsequently 
found matches based on combinations of these factors and county in order to get three 
matches. There were five BCCP women without any available “matching” controls; they 
were still included in the BCCP analytic group. We derived the same dependent and 
independent variables for the BCCP group and the comparison group of women (n = 
10,086), identifying all comparison women as non-BCCP users.
Regression variables
From the BCCP Enrollment and Patient Information, we used DOB, dates of each screening 
visit, type of screening visit (diagnostic, routine), screening results (normal, abnormal), age, 
race/ethnicity, and zip/county of residence for each woman in our study cohort. From the 
CMS two Beneficiary Annual Summary File (BASF), we derived data on evidence and 
indicators of 21 chronic conditions, Medicare coverage type (A, B, A/B, HMO), dates of 
birth and death, dates that their Medicare coverage started, and Medicare status code 
(disabled).
We derived dependent variables that indicated whether the woman was screened (diagnostic 
or routine) within 18 or 24 months of her enrollment in Medicare by starting with her actual 
date of Medicare enrollment and examining claims to see whether the procedure codes noted 
below were observed with service dates in our follow-up periods. We report results for the 
18-month period although the results are similar using the 24-month follow-up. Using the 
combination of the BCCP and Medicare claims data, we derived the time of screening since 
the woman first used BCCP, the time of screening since Medicare coverage began, the 
number of screens she received in BCCP and through Medicare, and the time between 
screens in each program, for those with multiple screens. The BCCP data denoted whether 
the screen was diagnostic or routine screening while procedure codes in the Medicare claims 
were used. Specifically, HCPCS procedure codes used to indicate diagnostic screens were 
76090, 76091, 77051,77055, 77056, G0204, G0205, G0206,G0207, and 76082; HCPCS 
codes used to denote routine screens were 77052, 77057, G0202, G0203, 76092,76085, and 
76083.
Our key independent variable was whether the woman was a BCCP user and if a user, a 
“regular” user. Since we observed a variety of screening patterns among women ever 
screened in the BCCP, we tested whether we would observe a sizeable number of women 
who were: (1) screened more than once and (2) if rescreened, the interval was less than 18 or 
24 months. Those screened more than once and re-screened within 18 months were then 
categorized as “regular” users. We derived a categorical independent variable including: (1) 
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any use of BCCP but not a “regular” user; (2) “regular” user of BCCP; and (3) non-BCCP 
user as the reference group.
To account for health status, we used CMS data for chronic conditions; these data include a 
yearly indicator and a first occurrence (1999 is earliest date) for 21 conditions. We collapsed 
their list into a subset based on prior literature and on significance levels. Other covariates in 
the model included: (1) race/ethnicity (Black non-Hispanic, Hispanic/other, and White non-
Hispanic as reference group); (2) Medicare coverage during our follow-up period (Part A 
only, Part A and B non-continuous, Part A and B continuous as reference group); and (3) 
disabled (non-disabled as reference group). We note that women will receive screening 
services largely under Medicare Part B since this covers physician and outpatient service 
while Part A is largely for inpatient services. Finally, to control for unobserved time 
invariant county characteristics that may affect the woman's access to insurance and 
screening services, we used county indicators and estimate a fixed-effect model.
Logistic regressions were run for the full sample and for subsamples of women by race and 
by evidence of a breast cancer diagnosis as found in the Medicare comorbidity data, using 
Stata Statistical Software: Release 13. Marginal effects of each independent variable were 
estimated using the margins function within STATA. The sample for regression analysis 
excluded those women who died within 24 months of their Medicare start date; regression 
results were not affected by this exclusion.
Results
Descriptive: BCCP and non-BCCP women
Descriptive data for BCCP and matched non-BCCP women aging into Medicare 2000–2005 
are shown in Table 2. Statistical significance is noted; there are no differences by race/
ethnicity since the comparison group was matched on these characteristics. Data indicate 
that BCCP women are less likely to have only Part A coverage (1.9 vs. 4.0 %) and if 
covered by Part B, less likely to have non-continuous coverage (4.6 vs. 6.5 %). BCCP 
women are far less likely to be disabled (7.3 vs. 17.9 %); low-income disabled women 
would qualify for coverage under other public programs. Consistent with lower levels of 
disability, BCCP women were less likely to have any of the comorbidities listed with the 
exceptions of diabetes (17 % for both), breast cancer (1.4 vs. 1.8 %), colorectal (0.7 vs. 0.5 
%), lung (0.4 vs. 0.3 %), and endometrial (0.3 for both) cancers. While almost 84 % of 
BCCP repeat users return within 18 months (see Table 3), and these women are identified as 
“regular” users of BCCP, this proportion drops to around 81 % (see Table 3) when they are 
under Medicare coverage. Yet, this is higher than non-BCCP users at 78 %. The first 
mammogram (diagnostic or screening) is received within 18 months of Medicare enrollment 
for less than half of non-BCCP users but for 60 % of BCCP users.
We also used GCR and linked BCCP data to examine the overall incidence of breast cancer 
in the Georgia population and differences in the stage at diagnosis of BCCP cases and non-
BCCP women. As shown in Fig. 1, older women with a breast cancer diagnosis in Georgia 
tend to be diagnosed at localized or in situ compared to younger women (71 vs. 67 %), and 
large disparities exist across races regardless of age. The data in Fig. 2 indicate that the stage 
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at diagnosis for women who ever used the BCCP, regardless of whether the diagnosis was 
before or after age 65 and Medicare coverage, I, is more likely localized or in situ than those 
actually diagnosed during a BCCP screening; this also holds when comparing BCCP women 
to all GA breast cancer cases.
Regression results
The results in Table 4 are marginal effects and can be interpreted, for example, as the 
difference in the probability of being screened (diagnostic or routine) within 18 months of 
Medicare enrollment for any BCCP user and “regular” BCCP users, versus non-BCCP 
users, controlling for Part A/B coverage, disability status, and the presence of comorbidities.
Results indicate that women who had any BCCP use were 3.5 % points more likely than 
non-BCCP users to be screened within 18 months of Medicare enrollment while “regular” 
users were even more likely to be screened, almost 18 % points, within that time frame than 
non-BCCP users. While White non-Hispanic women who ever used the BCCP showed no 
difference in the probability of screening, both ever and regular users among Black non-
Hispanics had significantly higher probabilities (13.7–22.4 % points) than Blacks who never 
used the BCCP.
Results indicate that enrollment in only Medicare Part A markedly reduces the probability of 
being screened (50 % points) and having non-continuous Part B coverage and the 
probability by almost 23 % points relative to having Part A and continuous Part B coverage. 
Women with disability, regardless of race, are less likely to be screened.
Having certain comorbidities (dementia and COPD) reduce the probability of screening 
while others (osteoporosis/arthritis/hip fracture; cataract/glaucoma and breast cancer) are 
associated with increased probabilities of screening. To assess whether these patterns hold 
for women without a history of breast cancer, we tested models (available upon request) 
omitting that group; patterns are largely stable overall and across races.
Discussion
This study adds to the literature on the NBCCEDP by focusing on older, low-income women 
using the NBCCEDP in a state, which has incorporated a specific component, client 
navigators, to assist BCCP clients in overcoming obstacles to screening such as cost, lack of 
knowledge about guidelines, lack of information about screening locations, language, and 
transportation. Many older women use the BCCP for regular screening before aging into 
Medicare, and the program's targeted outreach and education appear to promote significantly 
higher levels of regular and timely screening as they age out of the BCCP. Whether due to 
the client navigator component or unobserved characteristics of women who are BCCP 
users, we find that Georgia women who use this state's NBCCEDP are more likely than 
other Medicare enrollees to obtain breast screening soon after aging into Medicare. The 
effects found here were stronger for non-Hispanic Black women who were regular users of 
BCCP, an important finding given continued racial disparities in stage at time of diagnosis. 
[12].
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The results presented here suggest there may be a long-term benefit of the BCCP to former 
participants through instilling and promoting positive screening behaviors that result in 
cancers detected at an earlier stage than those detected among women who never 
participated in the BCCP. Our finding that women diagnosed during BCCP screenings are 
diagnosed at earlier stages, however, may simply reflect that these diagnoses occur at a 
younger age since women aged 65+ are not eligible to be screened under BCCP if they have 
Part B coverage. Our finding that BCCP women diagnosed at any time are also diagnosed at 
earlier stages of disease suggests that their continued screening patterns under Medicare may 
lead to earlier detection. We also note that the largest absolute differences between the 
groups analyzed are with respect to the incidence of regional disease, with BCCP rates 
higher than those covered by Medicare and the Georgia population in general. It is hard to 
draw conclusions from this finding in the absence of information regarding grade, or 
receptor status. Receptor status, however, is a better indicator of possible treatment 
outcomes and which tumors would respond better to which treatments. We are not 
addressing any treatment options or outcomes in this paper.
A limitation of the study is that it is only for one state's NBCCEDP. While we included 
women who lived in Georgia while using the BCCP, we also included women who may 
have resided in other states once enrolled in Medicare. Since Medicare is a national program 
with uniform coverage, we can still assess their usage. There may be a small percentage of 
women who moved from one county to another within Georgia, but they would still have 
access to a BCCP site within each county largely through their local public health 
departments, which may not hold in other states. The BCCP maintains a roughly 2 % loss to 
follow-up rate for diagnostic completion among those women who are recommended for 
breast follow-up after their screening, which minimizes this concern. For women actually 
diagnosed with breast cancer in the BCCP, the number refusing treatment or who are lost 
prior to start of treatment is virtually zero.
The BCCP and other states' NBCCEDP provide important access to breast cancer screening 
and early detection among low-income women. How the NBCCEDP relates to Medicare and 
Medicaid is important for access to continued screening and if needed, treatment. The 
NBCCEDP has been linked to Medicaid through the Breast and Cervical Cancer Prevention 
and Treatment Act (BCCPTA), and evidence for Georgia [13] suggests that this linkage is 
critical for reducing time to enrollment/treatment among women with a cancer diagnosis. It 
is important that states maintain and improve their capacity to use surveillance and linked 
data systems to monitor screening, Medicare and Medicaid enrollment, and related outcomes 
for poor and near-poor women. In Georgia and other states that have opted out of the Patient 
Protection and Affordable Care Act (ACA), the NBCCEDP and BCCPTA will continue to 
be critical for addressing the needs of underserved women.
The NBCCEDP can be especially important to women as they get close to Medicare age; on 
average, women in our study cohort were 62 when they entered BCCP, perhaps when they 
lost connection to the work force and employer-sponsored insurance. Educational materials 
could make these women more aware of Medicare coverage in general and in particular, the 
“Welcome to Medicare” benefit. This is the first and free visit provided to new Medicare 
enrollees (within the first 12 months of enrollment in Medicare Part B) and includes an 
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evaluation of preventive screenings, including cancer screening [14]. Only 3 % of new 
Medicare enrollees were found to use this benefit in 2006, and the key reason was lack of 
knowledge about it [15]. Salloum et al. [16] report that newly enrolled Medicare eligible 
women did not take advantage of this benefit, and hence, mammography percentages among 
this group did not increase. Of newly enrolled women aged 65–66 without a history of 
breast cancer, 25 % reported a screening compared to 35 % of those aged 67–68 [16].
As women age, the presence of multiple chronic conditions can also influence their 
screening patterns. Moreover, guidelines do not recommend screening in women with 
limited life expectancies. Evidence indicates that older women, those in nursing homes and 
in particular, those with evidence of cognitive impairment are less likely to receive 
mammograms [17–19]. The presence of other comorbidities, such as rheumatoid arthritis, 
has not been associated with lower screening percentages [20]. Our results confirm the 
effect of dementia on lower probability of screening along with other prevalent conditions, 
such as COPD. Both physicians and their patients will need to make well-informed 
decisions regarding the benefits of continued screening among older women with and 
without comorbidities.
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Table 1
Flowchart showing derivation of BCCP sample
Category n
BCCP aging out 2000–2008 9,587
BCCP aging out 2000–2005 4,796
BCCP aging out 2000–2005
 Matched to Medicare beneficiary ID by Social Security Number 3,858
BCCP aging out 2000–2005
 Matched to Medicare beneficiary ID by Social Security Number and date of birth 3,666
BCCP aging out 2000–2005
 Matched to Medicare beneficiary ID by Social Security Number and date of birth and no HMO coverage in first 24 months of 
Medicare enrollment* 3,134
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Table 2
Characteristics of sample, BCCP, and non-BCCP users aging into Medicare
a
, 2000–2005
Demographic and clinical characteristics Full sample n = 13,320 Non-BCCP users n = 10,086 BCCP users n = 3,134
Race
 Non-Hispanic Black (%) 39.5 39.5 39.2
 Non-Hispanic White 56.4 56.3 56.7
 Other 4.1 4.1 4.1
Medicare coverage (first 24 months)
b
 Part A only 3.5 4.0 1.9***
 Part A with non-continuous part B 6.0 6.5 4.6
 Part A and B 90.4 89.5 93.5
Disabled 15.4 17.9 7.3***
Died within 24 months of Medicare start 3.0 3.2 2.1***
Comorbidities
c
 Cardiovascular disease (CVD) 15.2 16.5 11.0***
 Dementia 1.6 1.9 0.8***
 Osteoporosis/arthritis/hip fracture 16.7 17.8 13.3***
 Cataract/glaucoma 18.1 19.1 14.7***
 Chronic kidney disease 3.5 4.0 1.8***
 Chronic obstructive pulmonary disease 6.3 6.9 4.4***
 Diabetes 17.1 17.1 17.0
 Depression 9.0 9.6 7.2***
 Stroke/transient ischemic attack 3.0 3.5 1.5***
 Breast cancer 1.7 1.8 1.4
 Colorectal cancer 0.5 0.5 0.7
 Lung cancer 0.4 0.4 0.3








Any woman with at least one month of HMO coverage observed within the first 24 months of Medicare enrollment following their 65th birthdate 
is excluded from the sample
b
For some women (n = 1,561), their Medicare start date was before age 65; for these women, their 65th birthdate was used as their Medicare start 
date for purposes of the regression analysis. Almost all of these women are classified as disabled in the Medicare beneficiary files
c
Data on comorbidities are taken from the Medicare Chronic Condition Warehouse. Comorbidities are derived based on clinical codes found in 
claims data and first date of service













Adams et al. Page 14
Table 3
Breast cancer screening patterns among BCCP and non-BCCP users aging into Medicare
a
, 2000–2005
Screening patterns Full sample n = 13,320 Non-BCCP users n = 10,086 BCCP users n = 3,134
Mammograms
b
 and intervals under BCCP
 Only 1 39.4 % – 39.4 %
 ≥2 60.6 – 60.6
Pattern for those with ≥2 n = 1,900 n = 1,900
 ≤12 months 17.5 – 17.5
 13–18 months 66.2 – 66.2
 19–24 months 8.7 – 8.7
 >24 months 7.6 – 7.6
Mammograms
c
 and intervals under Medicare
 No mammogram 30.7 34.0 19.9***
 Only 1 15.6 15.1 17.4
 ≥2 53.7 50.9 62.7
Pattern for those with ≥2 n = 7,096 n = 5,130 n = 1,966
 ≤12 months 24.6 24.7 24.2**
 13–18 months 54.4 53.6 56.6
 19–24 months 10.9 10.8 11.2




 Within 18 months of Medicare start 50.3 47.1 60.4***
 Within 24 months of Medicare start 56.2 52.7 67.4***
Timing of screening mammograms
c
 under Medicare
 Within 18 months of Medicare start 44.5 41.7 53.5***








Any woman with at least one month of HMO coverage observed within the first 24 months of Medicare enrollment following their 65th birthdate 
is excluded from the sample
b
Mammograms include diagnostic or screening mammograms and are identified directly in the BCCP data
c
Diagnostic mammograms are identified in the Medicare data with HCPCS procedure codes: “76090,” “76091,” “77051,” “77055,” “77056,” 
“G0204,” “G0205,” “G0206,” “G0207,” “76082”; screening mammograms are identified in the Medicare data with HCPCS procedure codes: 
“77052,” “77057,” “G0202,” “G0203,” “76092,” “76085,” “76083”
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Table 4
Marginal effects of use of BCCP on the probability of (any) breast cancer screening under medicare in first 18 
months of enrollment by evidence of breast cancer and race/ethnicity
Independent variables for full sample
a Marginal effect: all women 
Full sample
Marginal effect: White non-
Hispanics
Marginal effect: Black non-
Hispanics
Any user BCCP
b 0.035** −0.024 0.137***
Regular user BCCP 0.177*** 0.156*** 0.224***
Part A only
c −0.506*** −0.410*** −0.307***
Part A, non-continuous part B
d −0.226***
Disabled −0.145*** −0.157*** −0.142***
Comorbidities
 Cardiovascular disease (CVD) 0.005 −0.012 0.025
 Dementia −0.111*** −0.165** −0.064
 Osteoporosis/arthritis/hip fracture 0.113*** 0.128*** 0.107***
 Cataract/glaucoma 0.120*** 0.098*** 0.145***
 Chronic kidney disease −0.042 −0.021 −0.050
 Chronic obstructive pulmonary disease −0.073*** −0.076** −0.053
 Diabetes 0.020 0.001 0.046**
 Depression −0.010 −0.027 0.038
 Stroke/transient ischemic attack −0.046 −0.034 −0.049
 Breast cancer 0.297*** 0.321*** 0.264***
 Colorectal cancer 0.086 0.042 0.171
 Lung cancer −0.084 −0.000 −0.347
 Endometrial cancer 0.152 0.324 −0.006








The sample excludes those women who died within 24 months of their Medicare start date. Additional covariates for the full sample include race 
and year aging into Medicare
b
Reference group is women who are non-BCCP users. Regular user is defined as BCCP users with more than one screen and a re-screening within 
18 months
c
Reference group is women with Part A and B continuous coverage over the 24 months
d
Part A only and Part A/Some B coverage were combined into one category due to small sample sizes
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